These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 8624264)

  • 1. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
    Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
    Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
    Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H
    Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation.
    Courage C; Budworth J; Gescher A
    Br J Cancer; 1995 Apr; 71(4):697-704. PubMed ID: 7710931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine.
    Courage C; Bradder SM; Jones T; Schultze-Mosgau MH; Gescher A
    Int J Cancer; 1997 Nov; 73(5):763-8. PubMed ID: 9398059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance.
    Utz I; Hofer S; Regenass U; Hilbe W; Thaler J; Grunicke H; Hofmann J
    Int J Cancer; 1994 Apr; 57(1):104-10. PubMed ID: 7908658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemosensitization of cancer cells by the staurosporine derivative CGP 41251 in association with decreased P-glycoprotein phosphorylation.
    Beltran PJ; Fan D; Fidler IJ; O'Brian CA
    Biochem Pharmacol; 1997 Jan; 53(2):245-7. PubMed ID: 9037258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C.
    Sachs CW; Safa AR; Harrison SD; Fine RL
    J Biol Chem; 1995 Nov; 270(44):26639-48. PubMed ID: 7592889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase inhibitor-induced alterations of drug uptake, cell cycle and surface antigen expression in human multidrug-resistant (Pgp and MRP) promyelocytic leukemia HL-60 cells.
    Sedlák J; Hunáková L; Suliková M; Chorváth B
    Leuk Res; 1997 May; 21(5):449-58. PubMed ID: 9225074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity.
    Conseil G; Perez-Victoria JM; Jault JM; Gamarro F; Goffeau A; Hofmann J; Di Pietro A
    Biochemistry; 2001 Feb; 40(8):2564-71. PubMed ID: 11327879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of staurosporine analogues on cell cycle, growth and viability in A549 cells.
    Courage C; Snowden R; Gescher A
    Br J Cancer; 1996 Oct; 74(8):1199-205. PubMed ID: 8883405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.
    Toullec D; Pianetti P; Coste H; Bellevergue P; Grand-Perret T; Ajakane M; Baudet V; Boissin P; Boursier E; Loriolle F
    J Biol Chem; 1991 Aug; 266(24):15771-81. PubMed ID: 1874734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells.
    Budworth J; Gant TW; Gescher A
    Br J Cancer; 1997; 75(9):1330-5. PubMed ID: 9155054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An N-myristoylated protein kinase C-alpha pseudosubstrate peptide that functions as a multidrug resistance reversal agent in human breast cancer cells is not a P-glycoprotein substrate.
    Bergman PJ; Gravitt KR; O'Brian CA
    Cancer Chemother Pharmacol; 1997; 40(5):453-6. PubMed ID: 9272125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein to a cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine.
    Ferry D; Boer R; Callaghan R; Ulrich WR
    Int J Clin Pharmacol Ther; 2000 Mar; 38(3):130-40. PubMed ID: 10739116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of vinblastine resistance by a new staurosporine derivative, NA-382, in P388/ADR cells.
    Miyamoto K; Wakusawa S; Inoko K; Takagi K; Koyama M
    Cancer Lett; 1992 Jun; 64(2):177-83. PubMed ID: 1351792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sphingosine stereoisomers on P-glycoprotein phosphorylation and vinblastine accumulation in multidrug-resistant MCF-7 cells.
    Sachs CW; Ballas LM; Mascarella SW; Safa AR; Lewin AH; Loomis C; Carroll FI; Bell RM; Fine RL
    Biochem Pharmacol; 1996 Aug; 52(4):603-12. PubMed ID: 8759033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.